(Q37776830)

23 August 2017

1 reference

title

Activation of the type I interferon pathway in primary Sjogren's syndrome (English)

1 reference

23 August 2017

Activation of the type I interferon pathway in primary Sjogren’s syndrome (English)

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

14 June 2024

author name string

Clio P. Mavragani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674271

14 June 2024

Mary K. Crow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674271

14 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20674271

14 June 2024

publication date

31 July 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0896841110000673?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

https://api.elsevier.com/content/article/PII:S0896841110000673?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

14 June 2024

published in

Journal of Autoimmunity

1 reference

23 August 2017

volume

35

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

225-231

1 reference

The geoepidemiology of Sjögren's syndrome

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

The role of epithelial cells in the pathogenesis of Sjögren's syndrome

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Persistent viral infection in primary Sjogren's syndrome: review and perspectives

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Activation of type I interferon in systemic lupus erythematosus

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Interferons and autoimmune disorders

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Peripheral blood gene expression profiling in Sjögren's syndrome

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Association between IFN-alpha and primary Sjogren's syndrome

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Immune Interferon in the Circulation of Patients with Autoimmune Disease

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism

14 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Interferon-alpha: a therapeutic target in systemic lupus erythematosus

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences

14 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Circulating DNA in systemic lupus erythematosus. Isolation and characterization

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease

14 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

The DNA methyltransferases of mammals

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements

14 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis

14 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription

14 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

14 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

14 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism

14 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Diverse functions for DNA and RNA editing in the immune system.

14 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

14 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Primer: epigenetics of autoimmunity

14 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Collaboration, genetic associations, and lupus erythematosus

14 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Genetic regulation of serum cytokines in systemic lupus erythematosus

14 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background

14 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Variant form of STAT4 is associated with primary Sjögren's syndrome

14 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Association of an IRF5 gene functional polymorphism with Sjögren's syndrome

14 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

The CGGGG insertion/deletion polymorphism of theIRF5promoter is a strong risk factor for primary Sjögren's syndrome

14 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome

14 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases

14 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose

14 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

A tribute to an outstanding immunologist - Ian Reay Mackay

14 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara

14 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

The mosaic of autoimmunity

14 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.012

14 June 2024

Identifiers

1 reference

23 August 2017

1 reference